Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
about
The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathwaySelective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screensRapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity.Didymin: an orally active citrus flavonoid for targeting neuroblastoma.Targeting multiple angiogenic pathways for the treatment of neuroblastoma.mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.Targeting angiogenesis for controlling neuroblastoma.Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell cultureDidymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastomaDivergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancerNew therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma.Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.p53 family: Therapeutic targets in neuroblastoma.Pharmacotherapy of neuroblastoma.Combined therapeutic effects of vinblastine and Astragalus saponins in human colon cancer cells and tumor xenograft via inhibition of tumor growth and proangiogenic factors.Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors.Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.AKT kinase pathway: a leading target in cancer research.The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research
P2860
Q28477838-E71E0851-3961-4F87-A797-2F3239E84C4CQ30987402-DC6C0814-45B2-4414-A95B-558737C58535Q33345588-C1FA10ED-12F2-4101-A348-9C7F256459C9Q33710161-9A82162E-E594-4544-BE59-EA53DAEAC417Q33995832-41CDD924-CD6E-4F70-B2BB-20AB691CFE38Q34231591-037916CF-531E-44E3-9B9B-50F88B7C8AA5Q34632966-275B3027-BF53-4339-8DC2-4ACC2ED0FEABQ35049970-F386242C-C80C-46BA-93D0-7E82A257ACBCQ35184831-AC62BD97-96E9-470F-94C4-A700943D0DF1Q35679387-6D871E20-9E99-4D3F-83EA-5850A944B006Q35803397-DBDE936D-516E-453C-89E4-447CA980C56DQ36500309-7F81F479-BB6F-4271-AE4D-40DEC84C550FQ36557133-4C079571-5211-4A0A-8D9D-BD88E466C85DQ36663932-E8C1E376-46EC-4F4E-AD1C-C4E52743E853Q36742629-6C2F152C-4314-417B-A248-EFEA47C0C16BQ37043008-6929B886-EE2C-4F38-A500-3BFA1C7C021AQ37373332-ADBA6A6F-F6EF-4CC9-93C2-357D3E81C2ECQ37707387-6381055E-AF6E-4900-9831-D4F41B7A7B5DQ37735199-75995AE7-07E2-4A57-9BB2-E201CFB072C0Q39012529-05A1DF1A-3939-4483-A16F-04628BA65B60Q39365297-0E021EF9-1227-4FD7-870C-49909B545BA5Q39635469-A36E07EF-EDD4-4480-83EA-AF5968454298Q40041609-BB2239B4-531C-4FCE-A675-B5D76D7B7977Q53079070-3D915834-5C4C-47E0-9A7B-86A2062C63FBQ58804592-2FBBF616-9285-46B7-94E6-11A5DF400073
P2860
Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Combined therapeutic effects o ...... , apoptosis, and angiogenesis.
@en
type
label
Combined therapeutic effects o ...... , apoptosis, and angiogenesis.
@en
prefLabel
Combined therapeutic effects o ...... , apoptosis, and angiogenesis.
@en
P2093
P50
P1476
Combined therapeutic effects o ...... , apoptosis, and angiogenesis.
@en
P2093
Annalisa Pezzolo
Beatrice Nico
Chiara Brignole
Danilo Marimpietri
Federica Piccardi
Michele Cilli
P304
P356
10.1158/1078-0432.CCR-06-2757
P407
P50
P577
2007-07-01T00:00:00Z